查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
手足口病治疗的全球市场 - 产业规模，占有率，趋势，机会，预测:各药物类型，各给药途径，各流通管道，各企业，各地区(2017年～2027年)
市场调查报告书
商品编码
1166582

手足口病治疗的全球市场 - 产业规模，占有率，趋势，机会，预测:各药物类型，各给药途径，各流通管道，各企业，各地区(2017年～2027年)

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type, By Route of Administration, By Distribution Channel, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球手足口病治疗市场，预计从2023年到2027年的预测期间内完成惊人的成长。

主要原因包含病毒感染疾病的发生数量增加，大规模的研究开发促进全球市场成长 。支撑市场成长的其他因素，是对研究开发活动的政府投资增加，製药製造商足迹扩大，发展的医疗保健基础设施整备，大众的意识提升，技术的进步等。还有临床试验阶段的手足口病治疗药的FDA核准的容易度，预计更加促进手足口病治疗市场成长。

本报告提供全球手足口病治疗市场相关调查，各市场区隔分析，市场动态，企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19对全球手足口病治疗市场的影响

第4章 VOC (客户的迴响)

第5章 摘要整理

第6章 临床试验分析

第7章 全球手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型(止痛药，非类固醇消炎剂，核苷类似体抗病毒药物)
    • 各给药途径(局部，口服，静脉内)
    • 各流通管道(医院药局，零售药局，线上药局)
    • 各企业(2021年)
    • 各地区
  • 市场地图

第8章 北美的手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型
    • 各给药途径
    • 各流通管道
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第9章 欧洲的手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型
    • 各给药途径
    • 各流通管道
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第10章 亚太地区的手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型
    • 各给药途径
    • 各流通管道
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第11章 南美的手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型
    • 各给药途径
    • 各流通管道
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第12章 中东、非洲的手足口病治疗市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各药物类型
    • 各给药途径
    • 各流通管道
    • 各国
  • 中东、非洲:各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国

第13章 市场动态

  • 促进因素
  • 课题

第14章 市场趋势与发展

第15章 竞争情形

  • Johnson & Johnson
  • GlaxoSmithKline plc.
  • Emergex Vaccines Holdings Ltd
  • Takeda Pharmaceutical Co Ltd
  • CJ HealthCare Corp.
  • Adimmune Corp

第16章 策略性建议

简介目录
Product Code: 13003

The global hand, foot, and mouth disease treatment market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of viral infections, and extensive research and development are propelling the growth of the market, globally. Hand, foot, and mouth disease also abbreviated as HFMD is a contagious disease which is caused by enterovirus genus majorly Coxsackievirus A16 and enterovirus A71. These viruses are majorly detected in children below age 10 and is usually spread through skin-to-skin contact, airborne respiratory droplets or by saliva. The other factors supporting the market's growth are, the increasing government investments on R&D activities, growing footprint of pharmaceutical manufacturers, developed healthcare infrastructure, rising awareness among the masses, and technological advancements. Also, ease in FDA approvals for hand, foot, and mouth disease (HFMD) drugs in clinical trial phase is further projected to drive the growth of hand, foot, and mouth disease treatment market.

High Prevalence of Viral Infection

Viral infections are very common in children below age 10 as they have very low immunity, and they often tend to put their hands in mouth. Hand, foot, and mouth disease (HFMD) is caused by a virus from the Enterovirus genus, most commonly the coxsackievirus. These viruses are transmitted from infected person to other. Owing to the large patient pool due to HFMD, the demand for hand, foot and mouth disease treatment is upsurging. Moreover, growth of the health care industry due to the growing incidences of viruses across the globe is facilitating the market growth. For instance, from 2013-2019, 15,316,710 probable cases of HFMD were reported. Out of these, 787,197 (5*1%) were laboratory confirmed and 76,982 (0*5%) were severe.

Growing Awareness and Research

Over the past few years, increase in awareness among masses about the hand, foot and mouth diseases is seen. Various awareness programs are initiated by governments of different nations, which are propelling the growth of the market. Hand, foot, and mouth disease is widespread pediatric disease which occurs in children under the age of 5. Owing to the rise in number of patients suffering from HFMD, demand for the drug discovery research is rising. This, in turn, propels the market growth. For instance, according to Iranian Journal of Public Health, a study conducted from 2008 to 2015 revealed the incidence of HFMD grew rapidly from 86.59/100,000 in 2009 to 203.16/100,000 in 2014. Moreover, heavy investments by governments and market players on R&D activities and clinical trials, are bolstering the market growth.

Market Segmentation

The global hand, foot, and mouth disease treatment market is segmented into drug type, route of administration, distribution channel, and company. Based on drug type, the market is divided into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. Based on route of administration, the market is divided into topical, oral, and intravenous. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development activities in the country.

Market Players

Johnson & Johnson, GlaxoSmithKline plc., Emergex Vaccines Holdings Ltd, Takeda Pharmaceutical Co Ltd, CJ HealthCare Corp., and Adimmune Corp are some of the leading companies operating in the market.

Report Scope:

In this report, global hand, foot, and mouth disease treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Hand, Foot, and Mouth Disease Treatment Market, By Drug Type:

Pain Relievers

Non-Steroidal Anti-inflammatory Drugs

Nucleoside Analogue Antivirals

  • Hand, Foot, and Mouth Disease Treatment Market, By Route of Administration:

Topical

Oral

Intravenous

  • Hand, Foot, and Mouth Disease Treatment Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

  • Hand, Foot, and Mouth Disease Treatment Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Hand, Foot, and Mouth Disease Treatment Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Hand, Foot, and Mouth Disease Treatment Market

4. Voice of Customer

5. Executive Summary

6. Clinical Trial Analysis

7. Global Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals)
    • 7.2.2. By Route of Administration (Topical, Oral, Intravenous)
    • 7.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 7.2.4. By Company (2021)
    • 7.2.5. By Region
  • 7.3. Market Map

8. North America Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Route of Administration
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Mexico Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Canada Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Distribution Channel

9. Europe Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Route of Administration
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Germany Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. United Kingdom Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Distribution Channel
    • 9.3.4. Italy Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Drug Type
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By Distribution Channel
    • 9.3.5. Spain Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Drug Type
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By Distribution Channel

10. Asia-Pacific Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Route of Administration
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. Asia-Pacific: Country Analysis
    • 10.3.1. China Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. India Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Japan Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Distribution Channel
    • 10.3.4. South Korea Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Drug Type
        • 10.3.4.2.2. By Route of Administration
        • 10.3.4.2.3. By Distribution Channel
    • 10.3.5. Australia Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Drug Type
        • 10.3.5.2.2. By Route of Administration
        • 10.3.5.2.3. By Distribution Channel

11. South America Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Drug Type
    • 11.2.2. By Route of Administration
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Drug Type
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Argentina Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Drug Type
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. Colombia Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Drug Type
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By Distribution Channel

12. Middle East and Africa Hand, Foot, and Mouth Disease Treatment Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Drug Type
    • 12.2.2. By Route of Administration
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Drug Type
        • 12.3.1.2.2. By Route of Administration
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. Saudi Arabia Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Drug Type
        • 12.3.2.2.2. By Route of Administration
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. UAE Hand, Foot, and Mouth Disease Treatment Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Drug Type
        • 12.3.3.2.2. By Route of Administration
        • 12.3.3.2.3. By Distribution Channel

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

  • 15.1. Johnson & Johnson
  • 15.2. GlaxoSmithKline plc.
  • 15.3. Emergex Vaccines Holdings Ltd
  • 15.4. Takeda Pharmaceutical Co Ltd
  • 15.5. CJ HealthCare Corp.
  • 15.6. Adimmune Corp

16. Strategic Recommendations